Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer

NCT00383266 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT00383266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00383266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2006
Completion date
June 30, 2010
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal neoplasms